FIELD: immunology.
SUBSTANCE: disclosed is a method of producing a human IgG antibody with authentic human immunoglobulin sequences, produced by hybridoma (trioma): mouse myeloma—human lymphocyte—human lymphocyte.
EFFECT: present invention can find further application in producing human IgG antibodies of required specificity.
3 cl, 1 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEUTRALIZING MONOCLONAL ANTIBODY BINDING TO RABIES VIRUS GLYCOPROTEIN G, DNA FRAGMENTS CODING SAID ANTIBODY, AND ANTIGEN-BINDING FRAGMENT | 2017 |
|
RU2718835C2 |
| PREPARATION BASED ON NEUTRALIZING MONOCLONAL ANTIBODIES BINDING WITH GLYCOPROTEIN OF RABIES VIRUS | 2018 |
|
RU2711553C1 |
| FUSED PARTNER CELL | 2007 |
|
RU2431667C9 |
| METHOD FOR PRODUCING HYBRID/CHIMERIC CELLS AND USING THEM | 2010 |
|
RU2536978C2 |
| RABIES VIRUS-SPECIFIC HUMAN NEUTRALIZING MONOCLONAL ANTIBODY AND NUCLEIC ACID AND METHODS ASSOCIATED WITH THEREOF | 2001 |
|
RU2272809C2 |
| TEAT-SYSTEM FOR ASSAY OF HUMAN ERYTHROCYTE KELL ANTIGEN | 2003 |
|
RU2248805C1 |
| HOMO SAPIENS/MUS MUSCULUS 1B9C7 HYBRID CULTURED CELL STRAIN: PRODUCER OF HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO THE PROTEOLYTIC DOMAIN OF BOTULINUM TYPE A TOXIN | 2021 |
|
RU2783897C1 |
| METHODS OF OBTAINING CELLS, DEMONSTRATING PHENOTYPIC PLASTICITY | 2010 |
|
RU2536941C2 |
| STRAIN OF HYBRID CULTURED CELLS OF HOMO SAPIENS / MUS MUSCULUS 8D4E9-BA-LF-PRODUCER OF HUMAN MONOCLONAL ANTIBODIES AGAINST LETHAL FACTOR OF ANTHRAX AGENT | 2018 |
|
RU2699193C1 |
| COMPOSITION (VERSIONS), METHOD AND ASSEMBLY FOR SEPARATING CELLS | 2003 |
|
RU2346039C2 |
